Ad26COVS1
A viral vector vaccine designed against SARS-CoV-2 developed by Johnson and Johnson. Its vector encodes the SARS-CoV-2 Spike protein.
Year introduced: 2022
PubMed search builder options
Subheadings:
Tree Number(s): D20.215.894.899.085.125
MeSH Unique ID: D000090984
Registry Number: JT2NS6183B
Entry Terms:
- COVID-19 Vaccine Johnson and Johnson
- COVID 19 Vaccine Johnson and Johnson
- Ad26.COV2.S
- Johnson and Johnson Covid-19 Vaccine
- Johnson and Johnson Covid 19 Vaccine
- JNJ-78436735
- JNJ78436735
- JNJ 78436735